The human immunodeficiency virus type 1 NEF protein binds the Src- related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism

Virology

Volumn 247, Issue 2, 1998, Pages 200-211

  Dutartre, Hélène ^a   Harris, Mark ^b   Olive, Daniel ^a   Collette, Yves ^a  

^a Unite119 Inst Natl Santeet R   (France)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; PRIMATES; RNA VIRUSES;

EID: 0032145709     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9244     Document Type: Article

References (76)

1. Aiken C., Konner J., Landau N. R., Lenburg M. E., Trono D. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 76:1994;853-864.
2. Aiken C., Trono D. Nef stimulates human immunodeficiency virus type 1 proviral dna synthesis. J. Virol. 69:1995;5048-5056.
3. Aldrovandi G. M., Zack J. A. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J. Virol. 70:1996;1505-1511.
4. Arold S., Franken P., Strub M. P., Hoh F., Benichou S., Benarous R., Dumas C. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure. 5:1997;1361-1372.
5. Baur A. S., Sass G., Laffert B., Willbold D., Cheng M. C., Peterlin B. M. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity. 6:1997;283-291.
6. Baur A. S., Sawai E. T., Dazin P., Fantl W. J., Cheng M. C., Peterlin B. M. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity. 1:1994;373-384.
7. Bodeus M., Maris C. A., Bougeret C., Ramos M. F., Benarous R. In vitro binding and phosphorylation of human immunodeficiency virus type 1 Nef protein by serine/threonine protein kinase. J. Gen. Virol. 76:1995;1337-1344.
8. Bolen J. B., Brugge J. S. Leukocyte protein tyrosine kinases: Potential targets for drug discovery. Annu. Rev. Immunol. 15:1997;371-404.
9. Booker G. W., Breeze A. L., Downing A. K., Panayotou G., Gout I., Waterfield M. D., Campbell I. D. Structure of an SH2 domain of the p85 alpha subunit of phosphatidylinositol-3-OH kinase. Nature. 358:1992;684-687.
10. Brady H. J., Pennington D. J., Miles C. G., Dzierzak E. A. CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO J. 12:1993;4923-4932.
11. Briggs S. D., Sharkey M., Sevenson M., Smithgall T. E. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 272:1997;17899-17902.
12. Chowers M. Y., Spina C. A., Kwoh T. J., Fitch N. J., Richman D. D., Guatelli J. C. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68:1994;2906-2914.
13. Cleghon V., Morrison D. K. Raf-1 interacts with Fyn and Src in a non-phosphotyrosine-dependent manner. J. Biol. Chem. 269:1994;17749-17755.
14. Coates K., Cooke S. J., Mann D. A., Harris M. Protein kinase C-mediated phosphorylation of HIV-1 nef in human cell lines. J. Biol. Chem. 272:1997;12289-12294.
15. Coates K., Harris M. The human immunodeficiency virus type 1 Nef protein functions as a protein kinase C substrate in vitro. J. Gen. Virol. 76:1995;837-844.
16. Collette Y., Chang H. L., Cerdan C., Chambost H., Algarte M., Mawas C., Imbert J., Burny A., Olive D. Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 nef gene-induced expression. J. Immunol. 156:1996a;360-370.
17. Collette Y., Dutartre H., Benziane A., Ramosmorales F., Benarous R., Harris M., Olive D. Physical and functional interaction of nef with lck- hiv-1 nef-induced t-cell signaling defects. J. Biol. Chem. 271:1996b;6333-6341.
18. Collette Y., Olive D. Non-receptor protein tyrosine kinases as immune targets of viruses. Immunol. Today. 18:1997;393-400.
19. Cullen B. R. HIV-1: Is Nef a PAK animal. Curr. Biol. 6:1996;1557-1559.
20. Dechert U., Adam M., Harder K. W., Clark L. I., Jirik F. Characterization of protein tyrosine phosphatase SH-PTP2. Study of phosphopeptide substrates and possible regulatory role of SH2 domains. J. Biol. Chem. 269:1994;5602-5611.
21. Du Z. J., Lang S. M., Sasseville V. G., Lackner A. A., Ilyinskii P. O., Daniel M. D., Jung J. U., Desrosiers R. C. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell. 82:1995;655-674.
22. Eck M. J., Shoelson S. E., Harrison S. C. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck. Nature. 362:1993;87-91.
23. Franchini G., Robert G. M., Ghrayeb J., Chang N. T., Wong S. F. Cytoplasmic localization of the HTLV-III 3′ orf protein in cultured T cells. Virology. 155:1986;593-599.
24. Garcia J. V., Miller A. D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature. 350:1991;508-511.
25. Goldsmith M. A., Warmerdam M. T., Atchison R. E., Miller M. D., Greene W. C. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69:1995;4112-4121.
26. Greenway A., Azad A., McPhee D. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69:1995;1842-1850.
27. Greenway A., Azad A., Mills J., McPhee D. Human identify virus type 1 Nef binds directly to Lck and mitogen protein kinase, inhibiting kinase activity. J. Virol. 70:1996;6701-6708.
28. Gulizia R. J., Collman R. G., Levy J. A., Trono D., Mosier D. E. Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice. J. Virol. 71:1997;4161-4164.
29. Guy B., Kieny M. P., Riviere Y., Le P. C., Dott K., Girard M., Montagnier L., Lecocq J. P. HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature. 330:1987;266-269.
30. Howe L. R., Weiss A. Multiple kinases mediate T-cell-receptor signaling. Trends Biochem. Sci. 20:1995;59-64.
31. Iafrate A. J., Bronson S., Skowronski J. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16:1997;673-684.
32. Jamieson B. D., Aldrovandi G. M., Planelles V., Jowett J. B., Gao L., bBoch L. M., Chen I. S., Zach J. A. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68:1994;3478-3485.
33. Jung J. U., Lang S. M., Jun T., Roberts T. M., Veillette A., Desrosiers R. C. Downregulation of Lck-mediated signal transduction by tip of herpesvirus saimiri. J. Virol. 69:1995a;7814-7822.
34. Jung J. U., Lang S. M., Jun T., Roberts T. M., Veillette A., Desroisiers R. C., Biesinger B. Identification of Lck-binding elements in tip of herpesvirus saimiri. J. Biol. Chem. 270:1995b;20660-20667.
35. Kestler H. d., Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 65:1991;651-662.
36. Koch C. A., Anderson D., Moran M. F., Ellis C., Pawson T. SH2 and SH3 domains: Elements that control interaction of cytoplasmic signaling proteins. Science. 252:1991;668-674.
37. Lee C. H., Leung B., Lemon M. A., Zheng J., Cowburn D., Kuriyan J., Saksela K. A single amino acid in the sh3 domain of hck determines its high affinity and specificity in biding to hiv-1 nef protein. EMBO J. 14:1995;5006-5015.
38. Lee C. H., Saksela K., Mirza U. A., Chait B. T., Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell. 85:1996;931-942.
39. Legall S., Prevost M. C., Heard J. M., Schwartz O. Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity. Virology. 229:1997;295-301.
40. Lindemann D., Wilhelm R., Renard P., Althage A., Zinkernagel R., Mous J. Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3′-long terminal repeat transgene. J. Exp. Med. 179:1994;797-807.
41. Luo T., Downing J. R., Garcia J. V. Induction of phosphorylation of human immunodeficiency virus type 1 Nef and enhancement of CD4 downregulation of phrobol myristate acetate. J. Virol. 71:1997;2535-2539.
42. Luo W., Peterlin B. M. Activation of the T-cell receptor signaling pathway by Nef from an aggressive strain of simian immunodeficiency virus. J. Virol. 71:1997;9531-9537.
43. Luria S., Chambers I., Berg P. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA. 88:1991;5326-5330.
44. Malek S. N., Desiderio S. A cyclin-dependent kinase homologue, p130PITSLRE is a phosphotyrosine-independent SH2 ligand. J. Biol. Chem. 269:1994;33009-33020.
45. Messerschmitt A. S., Dunant N., Ballmer H. K. DNA tumor viruses and Src family tyrosine kinases, an intimate relationship. Virology. 227:1997;271-280.
46. Miller M. D., Warmerdam M. T., Gaston I., Greene W. C., Feinberg M. B. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:1994;101-113.
47. Moarefi I., LaFevre-Bernt M., Sicheri F., Huse M., Lee C., Kuriyan J., Miller W. T. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature. 385:1997;650-654.
48. Muller A. J., Pendergast A. M., Havlik M. H., Puil L., Pawson T., Witte O. N. A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction. Mol. Cell. Biol. 12:1992;5087-5093.
49. Ng D. H., Watts J. D., Aebersold R., Johnson P. Demonstration of a direct interaction between p561ck and the cytoplasmic domain of CD45 in vitro. J. Biol. Chem. 271:1996;1295-1300.
50. Notarangelo L. D. Immunodeficiencies caused by genetic defects in protein kinases. Curr. Opin. Immunol. 8:1996;448-453.
51. Nunn M. F., Marsh J. W. Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J. Virol. 70:1996;6157-6161.
52. Overduin M., Rios C. B., Mayer B. J., Baltimore D., Cowburn D. Three-dimensional solution structure of the src homology 2 domain of c-abl. Cell. 70:1992;697-704.
53. Panchamoorthy G., Fukazawa T., Stolz L., Payne G., Reedquist K., Shoelson S., Zhou S., Cantley L., Walsh C., Band H. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn. Mol. Cell. Biol. 14:1994;6372-6385.
54. Park I., Chung J., Walsh C. T., Yun Y., Strominger J. L., Shin J. Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region. Proc. Natl. Acad. Sci. USA. 92:1995;12338-12342.
55. Pascal S. M., Singer A. U., Gish G., Yamazaki T., Shoelson S. E., Pawson T., Kay L. E., Forman K. J. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide. Cell. 77:1994;461-472.
56. Pawson T. Protein modules and signalling networks. Nature. 373:1995;573-580.
57. Payne G., Shoelson S. E., Gish G. D., Pawson T., Walsh C. T. Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance. Proc. Natl. Acad. Sci. USA. 90:1993;4902-4906.
58. Pendergast A. M., Muller A. J., Havlik M. H., Maru Y., Witte O. N. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell. 66:1991;161-171.
59. Raffel G. D., Parmar K., Rosenberg N. In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction. J. Biol. Chem. 271:1996;4640-4645.
60. Ren R., Mayer B. J., Cicchetti P., Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science. 259:1993;1157-1161.
61. Rudd C. E., Janssen O., Cai Y. C., da S. A., Raab M., Prasad K. V. Two-step TCR zeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol. Today. 15:1994;225-234.
62. Saksela K., Cheng G., Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14:1995;484-491.
63. Sawai E. T., Baur A., Struble H., Peterlin B. M., Levy J. A., Cheng M. C. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. USA. 91:1994;1539-1543.
64. Sawai E. T., Khan I. H., Montbriand P. M., Peterlin B. M., Cheng M. C., Luciw P. A. Activation of PAK by HIV and SIV Nef: Importance for AIDS in rhesus macaques. Curr. Biol. 6:1996;1519-1527.
65. Schwartz O., Marechal V., Legall S., Lemonnier F., Heard J. M. Endocytosis of major histocompatibility complex class i molecules is induced by the hiv-1 nef protein. Nat. Med. 2:1996;338-342.
66. Shugars D. C., Smith M. S., Glueck D. H., Nantermet P. V., Seillier M. F., Swanstrom R. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo [published erratum appears inJ. Virol. J. Virol. 67:1993;4639-4650.
67. Skowronski J., Parks D., Mariani R. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12:1993;703-713.
68. Smith B. L., Krushelnycky B. W., Mochly R. D., Berg P. The HIV nef protein associates with protein kinase C theta. J. Biol. Chem. 271:1996;16753-16757.
69. Songyang Z., Shoelson S. E., Chaudhury M., Gish G., Pawson T., Haser W. G., King F., Roberts T., Ratnofsky F., Lechleider R. J., Neel B. J., Birge R. B., Fajardo J. E., Chou M. M., Hanafusa H., Schaffausen B., Cantley L. C. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
70. Spina C. A., Kwoh T. J., Chowers M. Y., Guatelli J. C., Richman D. D. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179:1994;115-123.
71. Straus D. B., Chan A. C., Patai B., Weiss A. Sh2 domain function is essential for the role of the lck tyrosine kinase in t cell receptor signal transduction. J. Biol. Chem. 271:1996;9976-9981.
72. Swingler S., Gallay P., Camaur D., Song J., Abo A., Trono D. The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix. J. Virol. 71:1997;4372-4377.
73. Trono D. HIV accessory proteins: Leading roles for the supporting case. Cell. 82:1995;189-192.
74. Vadlamudi R. K., Joung I., Strominger J. L., Shin J. p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J. Biol. Chem. 271:1996;20235-20237.
75. Waksman G., Kominos D., Robertson S. C., Pant N., Baltimore D., Birge R. B., Cowburn D., Hanafusa H., Mayer B. J., Overduin M., et a. l. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides [see comments]. Nature. 358:1992;646-653.
76. Wiskerchen M., Cheng M. C. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficienty proviral DNA synthesis. Virology. 224:1996;292-301.